Pioneering small dog spinal treatment available in UK

Pioneering Small Dog Spinal Treatment Now Available in the UK

The University of Cambridge’s Queen’s Veterinary School Hospital (QVSH) is the first in the UK to offer a new, minimally invasive treatment for severe intervertebral disc disease (IVDD) in small dog breeds.

Innovative Enzyme Injection Developed with US Collaboration

In partnership with Texas A&M University, Cambridge researchers co-developed a percutaneous intra-discal chondroitinase injection. This enzyme is delivered directly into damaged spinal discs to dissolve their central part, reducing pressure on the spinal cord.

Affordable Alternative to Open Spinal Surgery

This injection provides a "significantly more affordable" option compared to traditional open surgery, making advanced spinal care more accessible for small dogs.

Clinical Trial Demonstrates High Success Rates

A clinical trial involving 54 dogs unable to walk due to IVDD showed the treatment's effectiveness:

Of 41 dogs with intact pain sensation at the start, 38 regained the ability to walk 50 steps unaided within a median of 11 days.
Among 13 dogs without pain sensation initially, 4 recovered within 20 to 110 days after the injection.

Official Recognition and Usage

The Royal College of Veterinary Surgeons (RCVS) recognizes this procedure as routine veterinary practice. QVSH began offering this treatment early this year.

The injection offers a “significantly more affordable” alternative to open surgery.

Example Patient

Milo the dog, along with his owner Lani Swart, received this innovative treatment with positive outcomes.

Author's summary: A groundbreaking, cost-effective enzyme injection for severe spinal disc disease in small dogs is now available in the UK, showing promising recovery results and official veterinary recognition.

Vet Times — 2025-11-07